CAMBRIDGE, Mass., June 7, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Julian Adams, Ph.D., President and Chief Scientific Officer, will be presenting a company overview at the Sixth Annual Needham & Company, LLC Biotechnology & Medical Technology Conference being held June 13-14, 2007 in New York. Infinity's presentation will take place on Thursday, June 14, 2007, at 10:30 a.m. EDT.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.ipi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com. INFI-G